Cetriler

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cetriler

Quick Facts

Property Description
Active ingredient Cetirizine Hydrochloride
Form Oral preparations (e.g., tablet, solution, syrup)
Pharmacological class Antihistamine; Selective H1-receptor antagonist
Common use Systemic allergy mitigation
Origin Synthetic, Second-Generation compound

What Type of Medicine is Cetriler?

Cetriler is classified as a synthetic, single-agent medicine whose active ingredient is Cetirizine Hydrochloride. It belongs to the high-level pharmacological class of H1-receptor antagonists and is specifically a second-generation antihistamine. As a typical use scenario, this medicine is clinically recognized for providing relief from the systemic discomfort associated with common allergic reactions. Its structure is chemically derived from the older antihistamine hydroxyzine, distinguishing it from first-generation compounds.

Composition and General Purpose of Cetriler

Cetriler is manufactured as an oral preparation, commonly available in forms such as tablets, oral solution, or syrup, all intended for the oral route of administration. The composition relies solely on the active agent, Cetirizine Hydrochloride, within an inert base. This single-agent focus ensures that its fundamental purpose is systemic allergy mitigation, helping to reduce the overall physical discomfort associated with the body's overreaction to allergens. This type of medicine is useful for alleviating various allergic manifestations triggered by histamine release.

The Distinction of Second-Generation Antihistamines

Its key characteristic is the selective antagonism of peripheral H1 receptors, a property characterized by its minimal penetration of the central nervous system. This high receptor specificity is a core feature that defines the pharmacological advantage of Cetriler and other second-generation agents. It demonstrates that the medicine offers effective relief by targeting allergic pathways in the periphery while significantly reducing the potential for the pronounced sedating effects associated with older antihistamine compounds.

Regulatory References

  1. Cetirizine: MedlinePlus Drug Information
  2. Cetirizine - StatPearls - NCBI Bookshelf

What side effects are possible with Cetriler?

Possible Side Effects and Safety Information

The safety profile for Cetriler (Cetirizine Hydrochloride) is officially structured by frequency of occurrence and the System-Organ-Class (SOC) affected, as documented in regulatory information. Adverse reactions are grouped into categories from Common to Very Rare.

Documented Adverse Reactions

The most frequently observed adverse reactions are classified as Common (occurring in 1/100 to <1/10 patients) and generally involve the Nervous system and Gastrointestinal disorders. These include somnolence (drowsiness), headache, fatigue, and dry mouth [Table of Common Reactions]. Uncommon reactions (ge 1/1,000 to <1/100) include skin manifestations like pruritus (itching) and rash, and paraesthesia.

Classification Examples of Reactions (SOCs)
Common Somnolence, Fatigue, Headache, Dry mouth, Dizziness
Rare Hypersensitivity, Convulsions, Tachycardia, Abnormal liver function, Urticaria
Very Rare Anaphylactic shock, Angioneurotic Oedema, Syncope

Serious Adverse Reactions and Safety Constraints

Adverse reactions classified as Rare or Very Rare include serious events such as anaphylactic shock and convulsions. These require mandatory documentation in the regulatory label.

Official prescribing information includes specific safety constraints. Due to reduced drug clearance, Cetriler is contraindicated in individuals with severe, end-stage Renal Impairment (creatinine clearance <10 mL/ min), and caution is advised for patients with predisposing factors for urinary retention or those with epilepsy.

Exposure-Related Patterns

A specific, rare safety pattern documented in regulatory warnings is the occurrence of severe, generalized pruritus (itching) that may arise after the cessation of daily long-term therapy.

Overdose and Emergency Response

Overdose and when to seek help

An overdose of Cetriler (Cetirizine Hydrochloride) is officially documented in regulatory information as leading primarily to central nervous system effects. The most frequent manifestation of overdosage is profound drowsiness and somnolence, which can be accompanied by pronounced fatigue and general nervousness. In overdose cases involving children, the clinical presentation may initially include signs of restlessness and increased irritability before progressing to the typical state of sedation.

Severe overdosage may lead to more serious systemic manifestations. These include tachycardia (abnormally fast heart rate), pronounced agitation, hyperthermia (fever), and symptoms consistent with anticholinergic toxicity, such as hallucinations.

The official regulatory guidance mandates that immediate medical intervention is required for any suspected overdose. Seek emergency medical attention or contact a Poison Control Center right away when an overdose is suspected. This required action is due to the potential severity of symptoms.

Regarding medical management, regulatory documents specify that no known specific antidote exists for Cetirizine. Therefore, treatment is confined to measures that are strictly supportive and symptomatic in a monitored setting. Due to the medicine's physical properties, it cannot be effectively removed by dialysis. Specific caution is also noted for the management of overdose in individuals with pre-existing renal or hepatic impairment due to clearance concerns.

Therapeutic Uses of Cetriler

Cetriler is commonly used to help with symptomatic relief across the major domains of allergic discomfort, targeting the acute and persistent manifestations that may interfere with daily functioning. The medicine is applied in contexts where additional symptomatic support is needed for common allergic conditions, specifically addressing seasonal allergic rhinitis (hay fever), perennial allergic rhinitis, allergic conjunctivitis, and chronic idiopathic urticaria (hives).


Quick Facts: Therapeutic Support Domains

  • Relief Domain: Helps address symptom clusters related to heightened physiological activity in the upper respiratory tract and skin.
  • Symptom Focus: Is relevant for easing pronounced symptoms like sneezing, runny nose, itchy throat, itchy, watery eyes, and intense pruritus associated with hives.

This therapeutic support is considered relevant for easing symptoms related to heightened physiological activity. The overall benefit may assist with easing the functional strain, and supports patients during difficult episodes by easing distress.

“It contributes to easing the overall symptom load, particularly for patients dealing with persistent or recurrent skin and eye irritation.”

Regulatory References

  1. DailyMed NIH overview of Cetirizine

Eligibility and Restrictions for Use

Eligibility scope

Cetriler is generally approved for adults and adolescents 12 years and over, and for children as young as 6 months using specific oral formulations. Use of the tablet formulation is not recommended for children under six years due to the inability to achieve appropriate dose adaptation. The medicine is contraindicated in patients with a known hypersensitivity to the active substance, its excipients, or related compounds like hydroxyzine or piperazine derivatives.


Contraindicated and Conditional Use

Use is strictly contraindicated for patients diagnosed with severe renal impairment, defined as a creatinine clearance below 10 mL/min. Regulatory bodies mandate that patients with moderate renal impairment require a dose reduction, classifying this as conditional use. Caution is also necessary for patients with predisposing factors for urinary retention or those with a history of epilepsy or seizure risk, as Cetriler may increase these risks.


Age and Physiological Limitations

Regarding physiological states, Cetriler is not recommended for lactating women because the substance is excreted into breast milk. Use during pregnancy should only occur if clearly needed and when advised by a health professional. Eligibility for older adults must also consider the status of their renal function, as dose adjustment may be necessary if impairment is present.

What should I know about interactions with other medicines?

Cetriler's interaction profile outlines specific pharmacokinetic and pharmacodynamic constraints documented in regulatory labeling. The medicine’s primary clearance via renal excretion defines certain key restrictions.

Pharmacodynamic Interactions and Performance Impairment

Co-administration with Alcohol and other Central Nervous System (CNS) depressants, such as sedatives or tranquilizers, may lead to additional reductions in alertness and potential impairment of performance. While official studies indicate that cetirizine does not potentiate the acute effect of alcohol itself, the potential for an additive CNS depressive effect is noted in regulatory warnings.

Pharmacokinetic and Timing Constraints

One pharmacokinetic interaction of note is with Theophylline (400 mg once daily), which has been shown to cause a 16% decrease in the clearance of cetirizine. Conversely, specific studies with ketoconazole, erythromycin, azithromycin, and pseudoephedrine reported no clinically significant pharmacokinetic interactions. When taken with food, the overall extent of absorption is not reduced, but the rate of absorption is delayed.

Restrictions and Procedural Requirements

A mandatory procedural restriction requires that the use of Cetriler must be discontinued three days before scheduled Allergy Skin Testing to avoid interfering with the diagnostic histamine response. Due to the high risk of drug accumulation, the medicine is formally contraindicated in patients with Severe Renal Impairment (End-Stage Renal Disease) requiring dialysis.

Mechanism of Action

Cetriler acts as a small molecule inhibitor, directly targeting the farnesyl pyrophosphate synthase (FPPS) enzyme, a key component in the mevalonate pathway. This inhibition occurs through competitive binding at the active site of the enzyme, altering its conformational structure and preventing the conversion of isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) into geranyl pyrophosphate (GPP).

This primary molecular interaction initiates a downstream cascade. The reduced availability of GPP limits the subsequent synthesis of farnesyl pyrophosphate and geranylgeranyl pyrophosphate. These intermediates are crucial for the prenylation of various signaling proteins, particularly small GTPases such as Rac1, RhoA, and Cdc42.

System-Level Consequence: Modulation of Intracellular Signaling

The non-prenylated GTPases remain in the cytosol, inhibiting their ability to anchor to the plasma membrane and become biologically active. This disruption in membrane localization and subsequent signal transduction pathways modifies the intracellular signaling necessary for specific cellular functions, primarily affecting osteoclast activity and survival. Cetriler thus functions by modulating intracellular signal transduction pathways via upstream enzymatic inhibition.

Dosage and Administration Information

Cetriler (Cetirizine Hydrochloride) is administered via the oral route, using forms such as tablets, capsules, oral solutions, or syrups. The medicine is generally taken once daily, and administration is not dependent on meal times. Tablets should be swallowed with a glass of liquid, and overall absorption is maintained even when taken with food.


Standard Labeled Dosing Regimens

Population Usual Starting Dose Maximum Dose / Day
Adults & Adolescents (12+ years) 5 mg to 10 mg, once daily 10 mg
Children (6 to 12 years) 5 mg twice daily or 10 mg once daily 10 mg
Children (2 to 5 years) 2.5 mg once daily, or 2.5 mg twice daily 5 mg

Specific Usage Protocols

For individuals with moderate renal impairment, the dose requires adjustment due to reduced drug clearance. A common adjustment is 5 mg once daily. The tablet form is not recommended for children under 6 years of age, as low doses cannot be measured accurately; the oral solution is used for this age group.

If a dose is missed, the protocol is to take it as soon as remembered, but the forgotten dose is skipped and the regular schedule resumed if it is almost time for the next dose, avoiding a double dose. Furthermore, for patients undergoing allergy skin tests, the medicine is discontinued for several days prior to testing to ensure accurate results.

Recent Clinical Evidence

Evidence for use in Seasonal and Perennial Allergic Rhinitis

Research examined how Cetriler was observed in individuals experiencing both seasonal and perennial allergies. The primary method used in research exploring how symptoms change over time is the randomized controlled trial (RCT). These studies monitored changes in patient experiences using specific tools like the Total Symptom Score (TSSC), which measures outcomes related to physical discomfort, and the Quality of Life (RQLQ) scale. Studies monitored patterns observed in symptom scores and QOL assessments over short-term treatment periods, typically lasting two to four weeks. Data are still emerging regarding the durability of these patterns over very long periods, and the evidence base for effects sustained over a year or more is limited.


Evidence for use in Chronic Idiopathic Urticaria (Hives)

Cetriler was evaluated in individuals experiencing Chronic Idiopathic Urticaria (CIU), a condition characterized by fluctuating or episodic manifestations of hives and intense itching. Researchers examined outcomes related to systemic imbalance by monitoring the Urticaria Activity Score (UAS). Trial reports described measurement patterns in physician-rated scores for wheals and pruritus over treatment periods. Findings were mixed regarding the sustained effects in patients with severe, treatment-resistant CIU, and there is limited information for long-term outcomes regarding the continuous control of this condition.


Studies in Special Populations and Research Gaps

Cetriler was observed in various special populations, including pediatric patients, with studies monitoring outcomes in children as young as six months old. The research on allergic conjunctivitis also relied on controlled clinical efficacy trials, focusing on short-term measurement differences in ocular signs and itching. The evidence base does not fully describe measurement patterns in older adults, and data for certain groups remain insufficient. As most foundational efficacy trials were studied for short-term relief, long-term effects are not fully established regarding the durability of outcomes after years of administration. Research is ongoing to address these uncertainties and continue contributing to understanding symptom patterns.

Key Studies & References

  1. Cetirizine Hydrochloride Drug Information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Cetriler (FAQ)


Q: What is the main difference between Cetriler and other drugs used for similar conditions?

A: Cetriler is classified as a second-generation antihistamine. Official product information describes this class as selectively targeting H1 receptors in the body's periphery. This receptor targeting is associated with a minimal possibility of sedation compared to older, first-generation antihistamines.


Q: Is Cetriler known to cause trouble sleeping or insomnia?

A: According to regulatory safety information, the most frequently reported side effect affecting the central nervous system is somnolence, which is the medical term for drowsiness or sleepiness. This is listed as a common reaction. If sleep disturbance occurs while using this product, reviewing the pattern with a healthcare provider is recommended.


Q: How quickly does Cetriler usually start working after the first dose?

A: Regulatory documents indicate that the initial effects of Cetriler generally begin relatively quickly. Onset has been observed in clinical data to occur within 20 to 60 minutes after taking a single oral dose.


Q: Is it necessary to avoid certain foods or drinks while using Cetriler?

A: Official warnings advise against co-administration with alcohol because it may lead to additional impairment of alertness and performance. Food, however, does not reduce the overall amount of medicine absorbed by the body.


Q: What happens if I stop taking Cetriler suddenly?

A: Regulatory documents note a specific pattern observed with the discontinuation of long-term daily use. After stopping the medicine, a rare safety pattern reported is the occurrence of severe generalized itching (pruritus).


Q: Are there any known issues with taking Cetriler and over-the-counter pain relievers?

A: Clinical studies documented in official sources found no significant interactions with several drugs tested. However, the label does not explicitly list interactions with all common over-the-counter pain relievers. For clarity regarding all products used, consulting a healthcare provider is generally recommended.


Q: Does Cetriler have a known effect on weight?

A: Weight change is not listed as a common reaction in the official side effect profile. However, some clinical observations have noted an association with potential weight gain when the medicine is used over the long term.


Q: How long does the effect of Cetriler last throughout the day?

A: The medicine’s pharmacokinetic profile indicates that the effect persists for at least 24 hours. This sustained action is the reason Cetriler is administered as a once-daily dose.


Q: Can Cetriler interact with commonly prescribed medications for blood pressure?

A: Clinical studies indicate no major or clinically significant interactions with common blood pressure medications were found. The interaction profile of Cetriler is considered minimal with respect to this class of drugs.


Q: Is there any public research available on the long-term safety of Cetriler?

A: Yes, the safety of Cetriler has been the subject of multiple studies over time. Long-term safety studies are publicly available, including an 18-month prospective study conducted in pediatric populations.


Q: Are there warnings about using Cetriler in older adults (seniors)?

A: Official labeling states that adults 65 years and over are advised to consult a health professional. This is necessary to determine if a dose adjustment is required, often due to changes in kidney function that can occur with age.


Q: Does Cetriler need to be taken at the same time every day to be effective?

A: The medicine is prescribed to be taken once daily because its duration of action lasts for 24 hours or more. The instruction for a missed dose is provided, supporting flexible timing within the mandated once-daily regimen.


Q: Do studies suggest Cetriler is less effective over time?

A: Official research evidence does not generally suggest a loss of effectiveness over time (known as tachyphylaxis). While some studies noted mixed results on sustained effects in severe, treatment-resistant cases, overall efficacy is not generally associated with tachyphylaxis.


Q: Is there an easy way to understand what conditions Cetriler is approved to treat?

A: Yes, Cetriler is approved for the relief of symptoms related to several conditions. These officially indicated uses include Perennial and Seasonal Allergic Rhinitis (hay fever) and Chronic Idiopathic Urticaria (long-lasting hives).


Q: Can Cetriler cause issues with vision or eyesight?

A: Official safety information classifies blurred vision as a rare side effect of Cetriler. If visual disturbances are experienced, it is recommended to discuss this with a health professional.


Q: What is the meaning of the safety class or category Cetriler belongs to?

A: Cetriler is a second-generation antihistamine, a class known for minimal sedation. This means the medicine is chemically designed to target the allergic response in the body's periphery while limiting its action in the central nervous system.


Q: Are there specific symptoms that require immediate medical attention while on Cetriler?

A: Official safety documents list symptoms that may indicate a serious allergic reaction or other severe events requiring immediate medical attention. These may include swelling of the face, tongue, or lips, difficulty breathing, or a sudden severe rash.


Q: Can people with liver problems use Cetriler?

A: Regulatory labeling states that individuals with known liver or kidney disease are advised to consult a health professional. This is to ensure a review of the condition can determine if a change to the dose is necessary.


Q: What does the research say about Cetriler's effectiveness compared to a placebo?

A: The medicine’s approval by regulatory bodies is based on robust clinical trials, such as randomized controlled trials. These studies supported the efficacy and safety of Cetriler for its indicated conditions when compared to a control (often a placebo).


Q: Can Cetriler cause changes in mood or anxiety levels?

A: Regulatory safety documentation notes that rare adverse reactions have included mood or behavior changes. These reports specifically mention effects such as anxiety and agitation.


Q: Is it safe to drive or operate machinery while taking Cetriler?

A: Because drowsiness (somnolence) is a common side effect, official warnings advise caution when operating machinery or driving a car. This is recommended until the effects of the medicine are known.


Q: Is there a generic version of Cetriler available?

A: Yes. The active ingredient in Cetriler is Cetirizine Hydrochloride, which is the generic component. This ingredient is widely available from multiple manufacturers under its generic name.


Q: Is Cetriler known to interact with caffeine?

A: Based on available clinical data and drug interaction checkers, no interaction between the active ingredient and caffeine has been reported.

How should Cetriler be stored and disposed of?

The storage and disposal of Cetriler (Cetirizine Hydrochloride) must adhere strictly to regulatory labeling requirements to maintain product stability and safety.

Official Storage Conditions

Requirement Stated Condition
Temperature Store at Controlled Room Temperature, typically 20 to 25 C (68 to 77 F), with permitted excursions.
Protection Keep the medicine away from excess heat and moisture; storage in a bathroom is prohibited.
Container Maintain the product in its tightly closed original container.

Disposal and Safety Rules

The medicine must be stored out of the sight and reach of children; safety caps must always be secured. Unused or expired Cetriler must not be used after the expiration date and must be disposed of in accordance with local regulations.

Where drug take-back programs are unavailable, the FDA recommends mixing the medicine with an undesirable substance (e.g., used coffee grounds) before placing it in a sealed bag and discarding it in household trash. Wastewater disposal is prohibited.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cetriler found in:

A-Z Index: